| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/23/2009 | CN101606911A Risperidone dripping pill and preparing method thereof |
| 12/23/2009 | CN101606910A Ceftizoxime sodium drug injection powder and preparation method thereof, as well as synthetic method of bulk drug ceftizoxime sodium |
| 12/23/2009 | CN101606909A Amoxicillin powder injection and preparation method thereof |
| 12/23/2009 | CN101606908A Decoquinate soluble powder and preparation method thereof |
| 12/23/2009 | CN101606907A Fotemustine solid lipid nanoparticle and preparation method thereof |
| 12/23/2009 | CN101606906A Ursodeoxycholic acid nano suspension and preparation method thereof |
| 12/23/2009 | CN101606905A Nitazoxanide suspension for expelling parasite in livestock body and preparation method thereof |
| 12/23/2009 | CN101606903A Solution preparation for atomizing and inhaling ambroxol and preparation method thereof |
| 12/23/2009 | CN101606902A Contraceptive vagina gel with function of killing microorganism |
| 12/23/2009 | CN100572530C Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitro |
| 12/23/2009 | CN100572527C Medium for culturing autologous human progenitor stem cells and applications thereof |
| 12/23/2009 | CN100572399C Ultramicro chito polysaccharide product processing method |
| 12/23/2009 | CN100572383C Doriipenem hydrate crystal and preparation method thereof |
| 12/23/2009 | CN100572382C Heterocyclic compound capable of inversing tumor cell drug tolerance, preparation method and application thereof |
| 12/23/2009 | CN100572381C Pyrazolonaphthyridine derivative |
| 12/23/2009 | CN100572380C Berberine ion pair compound, preparing method and drug containing same |
| 12/23/2009 | CN100572379C Cgrp receptor antagonists |
| 12/23/2009 | CN100572378C Improved cinepazide maleate preparation method |
| 12/23/2009 | CN100572377C Derivatives of indol-2-one for treating neurological disorders, gastrointestinal disorders and cardiovascular disorder |
| 12/23/2009 | CN100572376C Imidazole derivatives used as TAFIA inhibitors |
| 12/23/2009 | CN100572375C Spiro-benzodioxoles and their use as CB1 antagonists |
| 12/23/2009 | CN100572374C Puerarin derivatives and their medical uses |
| 12/23/2009 | CN100572372C Salvianolic acid M and rosmarinic acid as aldose reductase inhibitor in sage |
| 12/23/2009 | CN100572365C 1,2,4-triazole [4,3-alpha] chinoline -1-one derivative as antiepileptics medicine and its pharmaceutical salts |
| 12/23/2009 | CN100572364C HIV replication inhibiting pyrimidines and triazines |
| 12/23/2009 | CN100572363C New imidazole derivative, method for producing the same and use of the same |
| 12/23/2009 | CN100572360C Isoquinoline compound and its salt preparation method and application |
| 12/23/2009 | CN100571785C Relativity between AnnexinA3 and drug resistance of platinum type chemical curing medication for cancer |
| 12/23/2009 | CN100571783C Glipizide controlled release tablets and preparation method thereof |
| 12/23/2009 | CN100571777C Composition containing ADP receptor antagonist and nitrate medicine |
| 12/23/2009 | CN100571776C Association between a PPAR ligand and an antioxidant agent and use thereof for treating obesity |
| 12/23/2009 | CN100571772C Use of integrin receptor alpha v beta 3 and /or alpha v beta 5 antagonist in preparing medicine for treating eye disease |
| 12/23/2009 | CN100571760C Prescription of mouth ulcer bilayer film and technique of preparing the same |
| 12/23/2009 | CN100571726C Medicinal compositions |
| 12/23/2009 | CN100571722C Medicine composition for treating deficiency of the kidney and climacteric syndrome and preparation method thereof |
| 12/23/2009 | CN100571715C Compositions containing bioactive materials, methods of preparation and treatment |
| 12/23/2009 | CN100571714C Blood replacing base liquid for blood purification treatment |
| 12/23/2009 | CN100571709C Medicinal composition with anti-tumor synergistic effect |
| 12/23/2009 | CN100571708C Medicinal composition having cooperative action |
| 12/23/2009 | CN100571707C Articular cavity injection formulation containing trehalose |
| 12/23/2009 | CN100571706C Preparation method of externally applied Chinese medicinal tincture for treating psoriasis |
| 12/23/2009 | CN100571705C Powder for treating scald |
| 12/23/2009 | CN100571704C Fixed dose compound preparation of antitubercular drug and its preparing method |
| 12/23/2009 | CN100571703C Sustained-release micro-pellet of trimetazidine and preparation process thereof |
| 12/23/2009 | CN100571702C Novel use of quinolone antibiotics |
| 12/23/2009 | CN100571701C Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 12/23/2009 | CN100571700C Carbazochrome sodium sulfonate slow-released tablet and its preparing method |
| 12/23/2009 | CN100571699C Selenophen compound for treating cancer and its medicine composition |
| 12/23/2009 | CN100571698C Extract of valid target in cudrania tricuspidata total flavone and method for preparing the same |
| 12/23/2009 | CN100571697C Drop pills of seabuckthorn fruit flavone |
| 12/23/2009 | CN100571696C Inhibitor or promoter of uridinediphosphate glucuronosyltransferase 2B (UGT2B) |
| 12/23/2009 | CN100571695C Bilayer pharmaceutical tablets comprising telmisartan and diuretic and their preparation |
| 12/23/2009 | CN100571694C Mesalazine colon target releasing micro pills and preparation method thereof |
| 12/23/2009 | CN100571693C Medicinal composition containing ibuprofen |
| 12/23/2009 | CN100571692C Application of turmeric element in the preparation of medicament for restraining uric acid transportor URAT1 |
| 12/23/2009 | CN100571691C Antineoplastic patches for external use of bullatacin |
| 12/23/2009 | CN100571690C External applied preparation for etodolac |
| 12/23/2009 | CN100571689C Transdermal therapeutic system provided with improved long-term attachment comfort |
| 12/23/2009 | CN100571687C Double sodium valproate orally disintegrating tablets and preparation method thereof |
| 12/23/2009 | CN100571685C Ropivacaine, and its pharmaceutical salt freeze-dried powder-injection preparation process |
| 12/23/2009 | CN100571684C Method for preparing high content beta-carotene water soluble nanometer particles |
| 12/23/2009 | CN100571683C Dry suspension and its preparation process |
| 12/23/2009 | CN100571682C Process for producing microparticles |
| 12/23/2009 | CN100571679C Lidocaine hydrochloride partial film forming gel composition and uses thereof |
| 12/23/2009 | CN100571677C Eucalyptus extracts |
| 12/23/2009 | CN100571540C Coco alkaline having carcinogenesis suppressing function |
| 12/23/2009 | CA2765866A1 Pharmaceutical formulation |
| 12/23/2009 | CA2739610A1 Dna-directed customization of analgesic compounds as a therapeutic modality |
| 12/23/2009 | CA2728979A1 Stabilization of amorphous drugs using sponge-like carrier matrices |
| 12/23/2009 | CA2728976A1 Combinations comprising methotrexate and dhodh inhibitors |
| 12/23/2009 | CA2728766A1 Compositions for the treatment of fibrotic diseases or conditions |
| 12/23/2009 | CA2728739A1 Compositions, methods, and kits for eliciting an immune response |
| 12/23/2009 | CA2728675A1 Dibenzothiazepine derivatives and use thereof |
| 12/23/2009 | CA2728664A1 Dermatological pharmaceutical composition for the treatment of skin inflammation diseases, such as dermatitis, atopic dermatitis, vitiligo, alopecia areata, acne, psoriasis, pruritus or combinations of them |
| 12/23/2009 | CA2728514A1 Paediatric compositions for treating multiple sclerosis |
| 12/23/2009 | CA2728466A1 Thienyl- and furanyl-isoquinolinones and methods for using them |
| 12/23/2009 | CA2728454A1 Thiazolyl- and oxazolyl-isoquinolinones and methods for using them |
| 12/23/2009 | CA2728408A1 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds |
| 12/23/2009 | CA2728376A1 6-1h-imidazo-quinazoline and quinolines derivatives/mao inhibitors for treating depression |
| 12/23/2009 | CA2728373A1 Aryl ketone as mri |
| 12/23/2009 | CA2728335A1 Novel phenylimidazole derivatives as pde10a enzyme inhibitors |
| 12/23/2009 | CA2728325A1 Topical composition for controlling ectoparasites in dogs and cats |
| 12/23/2009 | CA2728276A1 Combination therapies against cancer |
| 12/23/2009 | CA2728234A1 Use of isoindoles for the treatment of neurobehavioral disorders |
| 12/23/2009 | CA2728194A1 3-(3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives as met kinase inhibitors |
| 12/23/2009 | CA2728183A1 Compositions with and process for methylmorpholin-substituted pyrido [2,3-d] pryimidines |
| 12/23/2009 | CA2728156A1 Pyridone compounds |
| 12/23/2009 | CA2728155A1 Combination of a tiliroside and a peptide |
| 12/23/2009 | CA2728139A1 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases |
| 12/23/2009 | CA2728063A1 Pyrazole compounds 436 |
| 12/23/2009 | CA2728054A1 Pyrrolidine derivatives as nk2 receptor antagonists |
| 12/23/2009 | CA2728046A1 S1p1 receptor agonists and use thereof |
| 12/23/2009 | CA2728018A1 Quinoxalinedione derivatives |
| 12/23/2009 | CA2727987A1 Renin inhibitors and method of use thereof |
| 12/23/2009 | CA2727979A1 Crystalline of eszopiclone, its composition, preparation and uses thereof |
| 12/23/2009 | CA2727935A1 Preparation of controlled release skeletal muscle relaxant dosage forms |
| 12/23/2009 | CA2727928A1 Inhibitors of janus kinases |
| 12/23/2009 | CA2727926A1 Polyamine enhanced formulations for triptan compound iontophoresis |
| 12/23/2009 | CA2727923A1 Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives |
| 12/23/2009 | CA2727914A1 Spirodiamine-diaryl ketoxime derivative technical field |